semaphorin 3A antagonists (Hopital Maisonneuve-Rosemont/lUnivalor)

N/A

Report date: 2025/03/20 09:27:28
NME

Base Information

Drug Namesemaphorin 3A antagonists (Hopital Maisonneuve-Rosemont/lUnivalor)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSemaphorin-3A inhibitors
TargetsSemaphorin-3A
Therapy Area/IndicationsDiabetic macular oedema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHopital Maisonneuve-Rosemont
China Registration ClassN/A

Develop Information

Active CompaniesUnivalorHopital Maisonneuve-Rosemont
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A